News & Updates

Offsprings of women with polycystic ovarian syndrome (PCOS) – renamed as polyendocrine metabolic ovarian syndrome (PMOS) since May 2026 – exhibit cardiometabolic and reproductive alterations in young adulthood, researchers from the Chinese University of Hong Kong (CUHK) have reported.

Treatment with tirzepatide does not appear to be associated with atrial fibrillation or atrial arrhythmia in individuals with overweight or obesity, according to a meta-analysis.

In individuals with untreated HIV-1 infection, the two-drug dolutegravir/lamivudine (DTG/3TC) antiretroviral therapy (ART) regimen has similar efficacy as the three-drug bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) regimen, according to the phase IIIb VOGUE study.

A 10-year study in Japan has found that the seasonality of Kawasaki Disease (KD) has not returned to the usual winter-dominant pattern even after lifting the COVID-19 infection mitigation measures.

Patterns of thyroid-stimulating hormone (TSH) test show no substantial difference between type 2 diabetes patients treated with GLP-1 RAs and those who received SGLT-2 inhibitors, a study has found.

The novel oral orexin 2 receptor (OX2R) agonist alixorexton has demonstrated clinical benefits in patients with narcolepsy type 1, yielding improvements in wakefulness, excessive daytime sleepiness, and cataplexy, according to the phase II Vibrance-1 trial.

Researchers from the Chinese University of Hong Kong (CUHK) and the Chinese Academy of Sciences (CAS)–CUHK Joint Laboratory for Cardiovascular Sciences have discovered that de novo coronary collaterals formed after myocardial infarction (MI) arise primarily through arterialization of capillaries, with only a modest contribution from pre-existing arteries, challenging the long-held belief that new arteries arise from pre-existing arteries.